Stockscreener 앱 받기
14.00
0.70%
-0.0994
시간 외 거래:
14.00
전일 마감가:
$14.10
열려 있는:
$14
하루 거래량:
894
Relative Volume:
0.14
시가총액:
$36.64M
수익:
$5.02M
순이익/손실:
$-18.31M
주가수익비율:
-3.0905
EPS:
-4.53
순현금흐름:
$-23.40M
1주 성능:
-3.95%
1개월 성능:
-12.55%
6개월 성능:
-21.66%
1년 성능:
+3.78%
1일 변동 폭
$14.00
$14.00
1주일 범위
$14.00
$14.75
52주 변동 폭
$12.58
$26.99
Vtv Therapeutics Inc Stock (VTVT) Company Profile
명칭
Vtv Therapeutics Inc
전화
336-841-0300
주소
3980 PREMIER DR, HIGH POINT, NC
VTVT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VTVT
Vtv Therapeutics Inc
|
14.00 | 38.26M | 5.02M | -18.31M | -23.40M | -4.53 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Vtv Therapeutics Inc Stock (VTVT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-05-30 | 개시 | H.C. Wainwright | Buy |
| 2018-04-10 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-03-08 | 개시 | ROTH Capital | Buy |
| 2018-02-08 | 개시 | Northland Capital | Outperform |
| 2016-09-26 | 개시 | H.C. Wainwright | Buy |
| 2015-09-04 | 개시 | Canaccord Genuity | Buy |
| 2015-08-24 | 개시 | Piper Jaffray | Overweight |
| 2015-08-24 | 개시 | Stifel | Buy |
모두보기
Vtv Therapeutics Inc 주식(VTVT)의 최신 뉴스
Using fundamentals and technicals on vTv Therapeutics Inc.Free Weekly Watchlist of High Movers - Newser
Custom strategy builders for tracking vTv Therapeutics Inc.Smart Chart Forecasting with AI Algorithms - Newser
vTv Therapeutics Inc. stock retracement – recovery analysisDaily Stock Forecast Powered by AI Tools - Newser
Why vTv Therapeutics Inc. stock attracts strong analyst attentionOversold Reversal Picks with Buy Zone - Newser
Is vTv Therapeutics Inc. trending in predictive chart modelsFree High Return Stock Focus With Safety - Newser
Does vTv Therapeutics Inc. fit your quant trading modelFree Capital Protection Trading Strategies - Newser
What machine learning models say about vTv Therapeutics Inc.Daily Market Entry Strategy with Tools - Newser
What MACD and RSI say about vTv Therapeutics Inc.Free Low Risk Equity Screener With Results - Newser
What makes vTv Therapeutics Inc. stock price move sharplyFree Low Risk Equity Screener With Results - Newser
Should I buy vTv Therapeutics Inc. stock before earningsFree Access to Real-Time Trade Insights - Newser
How to monitor vTv Therapeutics Inc. with trend dashboardsBuy and Exit Strategy Based on Momentum - Newser
What’s next for vTv Therapeutics Inc. stock priceWeekly Movement Forecast With Chart Signals - Newser
How Resilient Is vTv Therapeutics Inc. Stock During Economic DownturnsFree Trade Setups With AI Powered Filters - Newser
Relative strength of vTv Therapeutics Inc. in sector analysisFree Exit Ready Momentum Stock Watchlist - Newser
vTv Therapeutics announces first participant randomized in CATT1 Phase 3 trial - TipRanks
vTv Therapeutics begins phase 3 trial for type 1 diabetes oral therapy - Investing.com
vTv Therapeutics Announces First Study Participant - GlobeNewswire
Advanced analytics toolkit walkthrough for vTv Therapeutics Inc.Chart Driven Opportunity Scanner with Alerts - Newser
First-Ever Oral Type 1 Diabetes Drug Enters Phase 3 TrialFDA Breakthrough Status Could Transform Treatment - Stock Titan
vTv Therapeutics (VTVT) Expected to Announce Quarterly Earnings on Thursday - Defense World
vTv Therapeutics Inc. stock daily chart insightsFree Community Verified Stock Suggestions - Newser
Using data models to predict vTv Therapeutics Inc. stock movementRisk-Managed Strategy Based on Price Analysis - Newser
vTv Therapeutics Inc expected to post a loss of 82 cents a shareEarnings Preview - TradingView
What are the technical indicators suggesting about vTv Therapeutics Inc.Invest smarter with data-backed trading alerts - Jammu Links News
What are analysts’ price targets for vTv Therapeutics Inc. in the next 12 monthsAchieve breakthrough financial growth - Jammu Links News
Is vTv Therapeutics Inc. a growth stock or a value stockDiscover undervalued opportunities early - Jammu Links News
Is it the right time to buy vTv Therapeutics Inc. stockAccelerated wealth building - jammulinksnews.com
Should I hold or sell vTv Therapeutics Inc. stock in 2025Free Stock Selection - Jammu Links News
What are vTv Therapeutics Inc. company’s key revenue driversStay informed with expert market forecasts - Jammu Links News
Is vTv Therapeutics Inc. a good long term investmentFree Stock Market Beginners Guide - Jammu Links News
Vtv Therapeutics Inc (VTVT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):